Anne Samuel

Stock Analyst at JP Morgan

(1.25)
# 1484
Out of 5,317 analysts
79
Total ratings
48.72%
Success rate
6.08%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
OMCL Omnicell
Maintains: Neutral
44 36
31.35 14.83% 5 Mar 20, 2025
VEEV Veeva Systems
Maintains: Neutral
218 249
222.42 11.95% 6 Mar 20, 2025
EVH Evolent Health
Maintains: Overweight
13 12
9.31 28.89% 12 Mar 10, 2025
IQV IQVIA Hldgs
Maintains: Overweight
240 232
149.23 55.46% 6 Feb 18, 2025
PGNY Progyny
Maintains: Neutral
17 23
21.77 5.65% 7 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 48
53.25 -9.86% 5 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 28
23.86 17.35% 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
19.45 -2.31% 4 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
19 21
19.11 9.89% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 13
3.71 250.4% 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 27
36.95 -26.93% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
7 5
2.51 99.2% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 108
83.02 30.09% 7 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 11
n/a n/a 3 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 25
n/a n/a 1 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
19 20
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 31
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
12
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
14 15
n/a n/a 4 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
148 159
n/a n/a 4 Apr 24, 2018